NARI Inari Medical Inc

Price (delayed)

$58.11

Market cap

$3.35B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.04

Enterprise value

$3.29B

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, ...

Highlights
The EPS has surged by 90% year-on-year and by 86% since the previous quarter
NARI's net income has soared by 88% year-on-year and by 83% since the previous quarter
The quick ratio has contracted by 28% YoY and by 7% from the previous quarter
Inari Medical's debt has increased by 4.2% YoY

Key stats

What are the main financial stats of NARI
Market
Shares outstanding
57.59M
Market cap
$3.35B
Enterprise value
$3.29B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.37
Price to sales (P/S)
7.11
EV/EBIT
1,169.45
EV/EBITDA
274.41
EV/Sales
7.01
Earnings
Revenue
$469.31M
EBIT
$2.81M
EBITDA
$11.99M
Free cash flow
$29.36M
Per share
EPS
-$0.04
Free cash flow per share
$0.51
Book value per share
$7.88
Revenue per share
$8.18
TBVPS
$9.56
Balance sheet
Total assets
$548.84M
Total liabilities
$96.69M
Debt
$32.26M
Equity
$452.14M
Working capital
$403M
Liquidity
Debt to equity
0.07
Current ratio
7.1
Quick ratio
6.37
Net debt/EBITDA
-4.75
Margins
EBITDA margin
2.6%
Gross margin
88.2%
Net margin
-0.6%
Operating margin
-2.3%
Efficiency
Return on assets
-0.5%
Return on equity
-0.6%
Return on invested capital
0.7%
Return on capital employed
0.6%
Return on sales
0.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NARI stock price

How has the Inari Medical stock price performed over time
Intraday
-0.56%
1 week
1.13%
1 month
1.08%
1 year
3.77%
YTD
-10.49%
QTD
-10.49%

Financial performance

How have Inari Medical's revenue and profit performed over time
Revenue
$469.31M
Gross profit
$414.12M
Operating income
-$10.63M
Net income
-$2.77M
Gross margin
88.2%
Net margin
-0.6%
Inari Medical's net margin has soared by 90% YoY and by 84% from the previous quarter
NARI's net income has soared by 88% year-on-year and by 83% since the previous quarter
The company's operating margin has surged by 60% YoY and by 55% QoQ
The operating income has soared by 53% from the previous quarter and by 48% YoY

Growth

What is Inari Medical's growth rate over time

Valuation

What is Inari Medical stock price valuation
P/E
N/A
P/B
7.37
P/S
7.11
EV/EBIT
1,169.45
EV/EBITDA
274.41
EV/Sales
7.01
The EPS has surged by 90% year-on-year and by 86% since the previous quarter
The equity is up by 9% year-on-year and by 3.8% since the previous quarter
The price to book (P/B) is 8% lower than the last 4 quarters average of 8.0
The revenue rose by 31% year-on-year and by 7% since the previous quarter
The P/S is 12% below the last 4 quarters average of 8.1

Efficiency

How efficient is Inari Medical business performance
NARI's return on invested capital has surged by 124% since the previous quarter and by 111% year-on-year
The return on sales has surged by 122% since the previous quarter and by 111% year-on-year
The company's return on assets has surged by 90% YoY and by 84% QoQ
The return on equity has surged by 90% year-on-year and by 84% since the previous quarter

Dividends

What is NARI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NARI.

Financial health

How did Inari Medical financials performed over time
The company's total liabilities rose by 33% YoY and by 8% QoQ
The quick ratio has contracted by 28% YoY and by 7% from the previous quarter
Inari Medical's debt is 93% less than its equity
The equity is up by 9% year-on-year and by 3.8% since the previous quarter
Inari Medical's debt has increased by 4.2% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.